reference/8579749

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8579749

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural
endingPage	63
issn	0920-1211
issueIdentifier	1
pageRange	54-63
publicationName	Epilepsy Research
startingPage	54
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a0eb2fadabf1dffb4d70280b760adba http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e57a2df28cd3d691c9ebea9a73b49d7b
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e6c5bbe848501bb2bc0bdbee4895ae1e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_62bb325c03dcec3d51af9ebe29b3aba7
bibliographicCitation	Argikar UA, Cloyd JC, Birnbaum AK, Leppik IE, Conway J, Kshirsagar S, Oetting WS, Klein EC, Remmel RP. Paradoxical urinary phenytoin metabolite (S)/(R) ratios in CYP2C191/2 patients. Epilepsy Res. 2006 Sep;71(1):54–63. doi: 10.1016/j.eplepsyres.2006.05.015. PMID: 16815679.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1004139f21f28493b7cf86e8120f80c1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f970b7b4c624b38096dbef198e88a02 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff7ef8619209cace8540ab78f3f7321b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4108b9691ff04742a6f8277f72017039 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5a18c6235274cf4c12d929c12f76fd0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_860792ba50ddc4e2c4b6e7726303f32c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d910965faaf4b9020b79b5d87e864c0c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b9ed7185b7d3f6297a1e4851d1a5494b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49ab73c4d9ab91a0ed4f7651c510be1f
date	200609
identifier	https://doi.org/10.1016/j.eplepsyres.2006.05.015 https://pubmed.ncbi.nlm.nih.gov/16815679
isPartOf	https://portal.issn.org/resource/ISSN/0920-1211 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Paradoxical urinary phenytoin metabolite (S)/(R) ratios in CYP2C191/2 patients
discusses	http://id.nlm.nih.gov/mesh/M0132976 http://id.nlm.nih.gov/mesh/M0010768 http://id.nlm.nih.gov/mesh/M0041605 http://id.nlm.nih.gov/mesh/M0001382 http://id.nlm.nih.gov/mesh/M0590604 http://id.nlm.nih.gov/mesh/M0016580 http://id.nlm.nih.gov/mesh/M0001774
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D010672Q000031 http://id.nlm.nih.gov/mesh/D006899Q000235 http://id.nlm.nih.gov/mesh/D000927Q000378 http://id.nlm.nih.gov/mesh/D010672Q000378 http://id.nlm.nih.gov/mesh/D001189Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D013237 http://id.nlm.nih.gov/mesh/D009154 http://id.nlm.nih.gov/mesh/D005838 http://id.nlm.nih.gov/mesh/D065731 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000927Q000652 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D010672Q000737 http://id.nlm.nih.gov/mesh/D016133 http://id.nlm.nih.gov/mesh/D010672Q000652 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D020641
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_61f7a5e5e1b7c9be084045f167e8a8b7 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148160 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7617 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17732 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135565956 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1775 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b360533648df9c14281910a5ec4e45f0 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135486137

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129676102 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129139370 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127692443

Total number of triples: 65.